(Q42645616)

English

Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

acute coronary syndrome

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Paul W. Armstrong

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

3

object named as

Califf RM

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Christopher B. Granger

10

object named as

Granger CB

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

author name string

Bahit MC

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Criger DA

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Hasselblad V

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Betriu A

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Hirsh J

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Ardissino D

9

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1001-1007

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Diagnosing and managing unstable angina. Agency for Health Care Policy and Research

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactivation of unstable angina after the discontinuation of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombin Generation, Inhibition and Clinical Outcomes in Patients With Acute Myocardial Infarction Treated With Thrombolytic Therapy and Heparin: Results From the GUSTO-I Trial fn1fn1This study was supported by Genentech, Inc., South San Francisco, C

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients. A double-blind, randomized, dose-finding study. Thrombin inhibition in Myocardial Ischaemia (TRIM) study group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactivation of the coagulation system: rationale for long-term antithrombotic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent thrombin generation during heparin therapy in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: potential mechanisms for heightened prothrombotic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic heparin concentrations augment platelet reactivity: implications for the pharmacologic assessment of the glycoprotein IIb/IIIa antagonist abciximab

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(01)01143-3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42645616&oldid=1964408114"